加拿大注资2.8亿加元支持Aspect Biosystems扩大生物打印组织疗法规模

The landscape of regenerative medicine is receiving a monumental boost. The Government of Canada has announced a massive $280 million project to support Vancouver-based bioprinting pioneer, Aspect Biosystems. This strategic investment is designed to accelerate the development and manufacturing of the company’s groundbreaking bioengineered cellular medicines, moving them closer to clinical reality and solidifying Canada’s position as a leader in biomanufacturing.

再生医学领域正迎来一项重大推动。加拿大政府宣布了一项高达2.8亿加元的重大项目，以支持总部位于温哥华的生物打印先驱企业Aspect Biosystems。这项战略性投资旨在加速该公司突破性生物工程细胞药物的研发与生产，使其更接近临床应用，并巩固加拿大在生物制造领域的领导地位。

The partnership was formally announced at Aspect Biosystems’ headquarters in Vancouver, British Columbia, with federal and provincial officials in attendance. The funding structure is a collaborative effort:

该合作伙伴关系在位于不列颠哥伦比亚省温哥华的Aspect Biosystems总部正式宣布，联邦和省级官员出席了仪式。资金结构是一项协作成果：

This initiative is part of a broader federal strategy to expand life sciences and biomanufacturing capacity, particularly in British Columbia, with over $125 million already earmarked to foster biotech innovation, create jobs, and build domestic capabilities.

该倡议是联邦扩大生命科学和生物制造能力更广泛战略的一部分，尤其侧重于不列颠哥伦比亚省。政府已拨出超过1.25亿加元用于培育生物技术创新、创造就业机会并建设国内能力。

Aspect Biosystems stands out in the bioprinting field by focusing not just on the printing hardware, but on developing complete, functional tissue-based therapies. The company’s goal is revolutionary: to use living cells to create tissues that can restore or replace biological functions in the body. Their research targets serious conditions like diabetes and other metabolic diseases, aiming to move beyond management with drugs like insulin to actual functional restoration.

Aspect Biosystems在生物打印领域的突出之处在于，它不仅专注于打印硬件，还致力于开发完整的、基于组织的功能性疗法。该公司的目标是革命性的：利用活细胞创建能够恢复或替代体内生物功能的组织。他们的研究针对糖尿病和其他代谢性疾病等严重病症，旨在超越使用胰岛素等药物进行管理的阶段，实现真正的功能恢复。

Their work involves building small, functional tissue structures. Key programs include developing insulin-producing tissue for diabetes and other cell-based therapies designed to support damaged organs. This represents a significant evolution in the field—from printing simple structures to engineering tissues with specific, life-sustaining functions.

他们的工作涉及构建小型功能性组织结构。关键项目包括开发用于糖尿病的胰岛素生成组织，以及其他旨在支持受损器官的细胞疗法。这代表了该领域的重大演进——从打印简单结构到设计具有特定、维持生命功能的组织。

The announcement underscores a concerted effort to build a cohesive life sciences ecosystem in Canada. The event brought together government, investors, researchers, and commercialization groups, including representatives from InBC Investment Corp and academic leaders from the University of British Columbia. This multi-level support system is crucial for translating cutting-edge research from the lab to the clinic.

此次公告突显了在加拿大建设一个紧密联系的生命科学生态系统的协同努力。活动汇集了政府、投资者、研究人员和商业化团体，包括InBC Investment Corp的代表以及不列颠哥伦比亚大学的学术领袖。这种多层次的支持系统对于将尖端研究从实验室转化到临床至关重要。

Aspect’s established track record, including a significant collaboration with global healthcare giant Novo Nordisk on diabetes treatments, demonstrates its credibility and clinical focus. While many in the additive manufacturing world are familiar with creating premium STL files for objects, Aspect is applying similar layer-by-layer precision to the most complex material of all: human biology.

Aspect已有的业绩记录，包括与全球医疗保健巨头诺和诺德在糖尿病治疗方面的重要合作，证明了其可信度和临床专注力。虽然增材制造领域的许多人熟悉为物体创建优质STL文件，但Aspect正在将类似的逐层精确度应用于最复杂的材料：人类生物学。

This substantial investment is a powerful vote of confidence in the future of bioprinted therapies. It signals a major step towards scaling production and conducting the clinical trials necessary to bring these treatments to patients. For enthusiasts of advanced manufacturing, it’s a fascinating glimpse into how the core principles of 3D printing are being used to solve some of medicine’s greatest challenges. The innovation driving this bioprinting revolution shares a foundational spirit with the creativity found in communities designing 3D printing models for countless other applications.

Looking for high-quality STL files? Browse our collection at 3dmis.com!

Original source: View Original

📌 编者按：本文改编自行业最新资讯。查看原文